Behind the Bell: Cytek Biosciences
Cytek Biosciences Chairman & CEO Wenbin Jiang speaks to the company’s mission, why they chose Nasdaq as their partner and how they are changing the cytometry industry.
Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowCytek Biosciences Chairman & CEO Wenbin Jiang speaks to the company’s mission, why they chose Nasdaq as their partner and how they are changing the cytometry industry.